Phosphodiesterase type 5 inhibitor administered immediately after radical prostatectomy temporarily increases the need for incontinence pads, but improves final continence status

PURPOSE: To evaluate the effects of phosphodiesterase type 5 inhibitor (PDE5i) on urinary continence recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). MATERIALS AND METHODS: Between 2002 and 2012, 137 of 154 consecutive patients who underwent BNSRP in our institution retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiho, Yasuhiro, Yamashita, Shinichi, Ito, Akihiro, Kawasaki, Yoshihide, Izumi, Hideaki, Kawamorita, Naoki, Adachi, Hisanobu, Mitsuzuka, Koji, Arai, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017554/
https://www.ncbi.nlm.nih.gov/pubmed/27617318
http://dx.doi.org/10.4111/icu.2016.57.5.357

Ejemplares similares

Ejemplares similares